1. Home
  2. MLTX vs DV Comparison

MLTX vs DV Comparison

Compare MLTX & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • DV
  • Stock Information
  • Founded
  • MLTX 2021
  • DV 2008
  • Country
  • MLTX Switzerland
  • DV United States
  • Employees
  • MLTX N/A
  • DV N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • DV Computer Software: Prepackaged Software
  • Sector
  • MLTX Health Care
  • DV Technology
  • Exchange
  • MLTX Nasdaq
  • DV Nasdaq
  • Market Cap
  • MLTX 2.8B
  • DV 2.5B
  • IPO Year
  • MLTX N/A
  • DV 2021
  • Fundamental
  • Price
  • MLTX $55.75
  • DV $16.22
  • Analyst Decision
  • MLTX Strong Buy
  • DV Buy
  • Analyst Count
  • MLTX 7
  • DV 18
  • Target Price
  • MLTX $74.83
  • DV $19.14
  • AVG Volume (30 Days)
  • MLTX 380.3K
  • DV 2.4M
  • Earning Date
  • MLTX 08-05-2025
  • DV 08-05-2025
  • Dividend Yield
  • MLTX N/A
  • DV N/A
  • EPS Growth
  • MLTX N/A
  • DV N/A
  • EPS
  • MLTX N/A
  • DV 0.31
  • Revenue
  • MLTX N/A
  • DV $714,259,000.00
  • Revenue This Year
  • MLTX N/A
  • DV $18.49
  • Revenue Next Year
  • MLTX N/A
  • DV $11.80
  • P/E Ratio
  • MLTX N/A
  • DV $51.75
  • Revenue Growth
  • MLTX N/A
  • DV 16.54
  • 52 Week Low
  • MLTX $31.42
  • DV $11.52
  • 52 Week High
  • MLTX $58.26
  • DV $23.11
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 59.35
  • DV 60.71
  • Support Level
  • MLTX $53.29
  • DV $15.22
  • Resistance Level
  • MLTX $56.78
  • DV $16.39
  • Average True Range (ATR)
  • MLTX 2.07
  • DV 0.42
  • MACD
  • MLTX -0.05
  • DV 0.07
  • Stochastic Oscillator
  • MLTX 78.36
  • DV 93.52

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

Share on Social Networks: